Consistent with data from previous studies, these findings proved the critical effect of IL4I1 in diverse tumor types, emphasizing the potential of developing IL4I1-targeting inhibitors as a prospective and broad-spectrum avenue for cancer therapy. Here, IL4I1 is linked to neoplasm.